8 Results for "

Levosimendan

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Levosimendan" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-14286
CAS No.: 141505-33-1
Purity:  99.82%
Synonyms: Simsndan; OR-1259; (4R)-Simendan
Levosimendan (Simsndan; OR-1259) is a calcium sensitiser used in the management of acutely decompensated congestive heart failure.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135746
CAS No.: 220246-81-1
Purity:  99.03%
OR-1896 is an active long-lived metabolite of Levosimendan. OR-1896 is a highly selective phosphodiesterase (PDE) III isoform inhibitor and a powerful vasodilator. OR-1896 can open ATP-sensitive K + channels and has Ca 2+-sensitizing effect. OR-1896 mitigates cardiomyocyte apoptosis, cardiac remodeling and myocardial inflammation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W050000
CAS No.: 101328-85-2
OR-1855, an active metabolite of Levosimendan (HY-14286), has effect on myometrial contractility. OR-1855 exerts anti-inflammatory effects by inhibiting IL-1β-induced ROS formation and NAD(P)H oxidase-dependent superoxide radical generation in HUVECs. OR-1855 inhibits IL-1β-induced phosphorylation p38 MAPK, ERK1/2, c-Jun and JNK in HUVECs. OR-1855 can be used for the study of inflammation .
loading...
    loading...
Cat. No.: HY-14286R
CAS No.: 141505-33-1
Synonyms: Simsndan (Standard); OR-1259 (Standard); (4R)-Simendan (Standard)
Levosimendan (Standard) is the analytical standard of Levosimendan. This product is intended for research and analytical applications. Levosimendan (Simsndan; OR-1259) is a calcium sensitiser used in the management of acutely decompensated congestive heart failure.
loading...
    loading...
Cat. No.: HY-FL14286
CAS No.: 141505-33-1
Synonyms: Simsndan solution; OR-1259 solution
Levosimendan solution is mainly composed of Levosimendan (HY-14286). Levosimendan (Simsndan; OR-1259) is a calcium sensitiser used in the management of acutely decompensated congestive heart failure.
loading...
    loading...
Cat. No.: HY-W050000R
CAS No.: 101328-85-2
OR-1855 (Standard) is an analytical standard of OR-1855 (HY-W050000). This product is intended for research and analytical applications. OR-1855, an active metabolite of Levosimendan (HY-14286), has effect on myometrial contractility. OR-1855 exerts anti-inflammatory effects by inhibiting IL-1β-induced ROS formation and NAD(P)H oxidase-dependent superoxide radical generation in HUVECs. OR-1855 inhibits IL-1β-induced phosphorylation p38 MAPK, ERK1/2, c-Jun and JNK in HUVECs. OR-1855 can be used for the study of inflammation .
loading...
    loading...
Cat. No.: HY-W745845
CAS No.: 131741-08-7
Synonyms: (rac)-Levosimendan; (rac)-Simsndan; (rac)-OR-1259
Research Areas:  

Cardiovascular Disease

Simendan ((rac)-Levosimendan; (rac)-Simsndan; (rac)-OR-1259) is a calcium-sensitizing positive inotropic vasodilator compound that enhances myocardial contractility through calcium-dependent binding to cardiac troponin C and selectively inhibits cardiac phosphodiesterase (Phosphodiesterase) III, while inducing coronary and peripheral vasodilation and anti-ischemic effects. Simendan can be used for research on congestive heart failure, acute heart failure, myocardial infarction, myocardial ischemia, and thrombotic diseases .
loading...
    loading...
Cat. No.: HY-135746S
OR-1896-d3 is the deuterium labeled OR-1896 (HY-135746). OR-1896 is an active long-lived metabolite of Levosimendan. OR-1896 is a highly selective phosphodiesterase (PDE) III isoform inhibitor and a powerful vasodilator. OR-1896 can open ATP-sensitive K+ channels and has Ca2+-sensitizing effect. OR-1896 mitigates cardiomyocyte apoptosis, cardiac remodeling and myocardial inflammation .
loading...
    loading...